Novartis Investigative Site

Hanau 63450

0 studies enrolling now · 2 studies all time

What they study most

Chronic Plaque Psoriasis, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed